UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058510
Receipt number R000066854
Scientific Title A Study on Cancer Screening for Individuals with Inconclusive NIPT Results
Date of disclosure of the study information 2025/08/01
Last modified on 2025/07/21 10:31:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on Cancer Screening for Individuals with Inconclusive NIPT Results

Acronym

A Study on Cancer Screening for Individuals with Inconclusive NIPT Results

Scientific Title

A Study on Cancer Screening for Individuals with Inconclusive NIPT Results

Scientific Title:Acronym

A Study on Cancer Screening for Individuals with Inconclusive NIPT Results

Region

Japan


Condition

Condition

Individuals with inconclusive NIPT results

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aimed to elucidate the association between inconclusive results of non-invasive prenatal testing (NIPT) and maternal malignancies by performing whole-body MRI-based cancer screening in pregnant women with inconclusive NIPT findings.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The incidence of cancers detected by whole-body MRI

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

MRI scan

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1.Individuals aged 18 years or older at the time of obtaining consent.

2.Pregnant individuals at 14 weeks of gestation or later, with an ongoing pregnancy and eligible for whole-body MRI.

3.Individuals who have received a thorough explanation of the study, fully understood its contents, and voluntarily provided written informed consent to participate.

Key exclusion criteria

1.Individuals with contraindications to MRI examinations (e.g., metallic implants, pacemakers).

2.Individuals with a history of malignant tumors.

3.Individuals deemed inappropriate for participation in the study by the principal investigator for any other reason.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Umazume

Organization

Hokkaido University Hospital

Division name

Department of Obstetrics and the Perinatal Center

Zip code

060-8648

Address

Kita 14-jo Nishi 5-chome, Kita-ku, Sapporo, Hokkaido, Japan

TEL

011-706-5941

Email

takeuma@med.hokudai.ac.jp


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name Umazume

Organization

Hokkaido University Hospital

Division name

Department of Obstetrics and the Perinatal Center

Zip code

060-8648

Address

Kita 14-jo Nishi 5-chome, Kita-ku, Sapporo, Hokkaido, Japan

TEL

011-706-5941

Homepage URL


Email

takeuma@med.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University Hospital

Institute

Department

Personal name



Funding Source

Organization

No funding

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hokkaido University Hospital Clinical Research Administration Center

Address

Kita 14, Nishi 5, Kita-ku, Sapporo, Hokkaido, 060-8648, Japan

Tel

011-716-1161

Email

crjimu@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 07 Month 14 Day

Date of IRB


Anticipated trial start date

2025 Year 08 Month 01 Day

Last follow-up date

2031 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 07 Month 18 Day

Last modified on

2025 Year 07 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066854